These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 8016179

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Clinical study of a C31G containing mouthrinse: effect on salivary microorganisms.
    Corner AM, Brightman VJ, Cooper S, Yankell SL, Malamud D.
    J Clin Dent; 1990; 2(2):34-8. PubMed ID: 2090157
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. C31G, a new agent for oral use with potent antimicrobial and antiadherence properties.
    Corner AM, Dolan MM, Yankell SL, Malamud D.
    Antimicrob Agents Chemother; 1988 Mar; 32(3):350-3. PubMed ID: 3364952
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of a surfactant mixture C31G as a teat dip by a modified excised teat model.
    Amin MM, Smith AR, Anderson KL, Hahn EC, Gustafsson BK.
    J Dairy Sci; 1984 Feb; 67(2):421-6. PubMed ID: 6425375
    [Abstract] [Full Text] [Related]

  • 6. A randomized Phase I vaginal safety study of three concentrations of C31G vs. Extra Strength Gynol II.
    Mauck CK, Weiner DH, Creinin MD, Barnhart KT, Callahan MM, Bax R.
    Contraception; 2004 Sep; 70(3):233-40. PubMed ID: 15325893
    [Abstract] [Full Text] [Related]

  • 7. A phase I comparative postcoital testing study of three concentrations of C31G.
    Mauck CK, Creinin MD, Barnhart KT, Ballagh SA, Archer DF, Callahan MM, Schmitz SW, Bax R.
    Contraception; 2004 Sep; 70(3):227-31. PubMed ID: 15325892
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Assessment of the anti-microbial agent C31G as a spermicide: comparison with nonoxynol-9.
    Thompson KA, Malamud D, Storey BT.
    Contraception; 1996 May; 53(5):313-8. PubMed ID: 8724622
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The release of naproxen in fatty suppository bases by beta-cyclodextrin complexation.
    Celebi N, Iscanoglu M, Degim T.
    Pharmazie; 1991 Dec; 46(12):863-5. PubMed ID: 1818322
    [Abstract] [Full Text] [Related]

  • 13. [Comparison of in vitro model examinaitons with respect to drug release from suppositories].
    Regdon G, Vágó I, Mándi E, Regdon G, Erós I.
    Acta Pharm Hung; 2000 Apr; 70(2):45-51. PubMed ID: 11192740
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. In vitro release of amoxycillin from lipophilic suppositories.
    Webster JA, Dowse R, Walker RB.
    Drug Dev Ind Pharm; 1998 Apr; 24(4):395-9. PubMed ID: 9876601
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Inactivation of human immunodeficiency virus type 1 by nonoxynol-9, C31G, or an alkyl sulfate, sodium dodecyl sulfate.
    Krebs FC, Miller SR, Malamud D, Howett MK, Wigdahl B.
    Antiviral Res; 1999 Oct; 43(3):157-73. PubMed ID: 10551374
    [Abstract] [Full Text] [Related]

  • 20. In vitro release of meclozine hydrochloride from lipophilic suppository bases with or without tensides.
    Bećirević M, Petricić V, Kallay N.
    Pharmazie; 1984 Dec; 39(12):828-30. PubMed ID: 6531391
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.